Overview
BrainCo develops EEG-based brain-computer interface technology for prosthetics, education, and performance optimization, with their Focus edu device used in classrooms to monitor student attention. Their BrainRobotics prosthetic hand uses neural signals to enable intuitive motor control for amputees.
BrainCo is a neurotechnology company headquartered in Somerville, Massachusetts, specializing in electroencephalography-based brain-computer interface solutions across multiple application domains. Founded out of Harvard University's Innovation Lab, the company develops hardware and software platforms that translate neural signals into actionable outputs for end users. Their product portfolio spans two primary verticals: educational technology and advanced prosthetics. The Focus edu device captures real-time EEG data to monitor and quantify student attention levels in classroom environments, providing educators with biometric feedback to improve learning outcomes. Their BrainRobotics prosthetic hand leverages electromyography and neural signal processing to enable amputees to control a robotic limb through intuitive, thought-driven motor commands.
BrainCo has secured over $80 million in Series B funding, reflecting strong investor confidence in its dual-market strategy and the commercial viability of its core technology. The company has deployed its Focus edu platform across classrooms in multiple countries, gaining traction particularly in Asian education markets where performance optimization tools have seen notable adoption. The BrainRobotics hand has drawn international attention for its affordability relative to competing prosthetic solutions, positioning it as an accessible option in a historically cost-prohibitive market segment. BrainCo has demonstrated clinical progress through user trials with amputees, showcasing meaningful improvements in dexterity and responsiveness compared to conventional myoelectric prosthetics.
BrainCo represents a significant force in the neurotech industry by demonstrating that EEG-based brain-computer interface technology can scale beyond research settings into real-world consumer and clinical applications. Their ability to operate credibly across both the prosthetics and education sectors illustrates the broad utility of neural signal interpretation as a platform technology. By prioritizing accessibility and practical deployment, BrainCo is helping to normalize brain-computer interfaces as functional tools rather than experimental novelties. This approach contributes meaningfully to expanding the addressable market for neurotech and accelerating broader societal acceptance of neurotechnology in everyday life.
More in Brain-Computer Interfaces
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 · Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🧠 Brain-Computer Interfaces
Location
Somerville, MA, USA
Funding
Series B · $80M+
Website
brainco.techListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →